Manlay L, Boschetti G, Pereira B, Flourie B, et al. Comparison of short- and long-term effectiveness between ustekinumab and vedolizumab in patients with Crohn's disease refractory to anti-tumour necrosis factor therapy. Aliment Pharmacol Ther 2021;53:1289-1299.
PMID: 33909920